PipelineRx Partners with YouScript for Personalized Prescribing Capabilities
Solution Fully Integrated with PowerGridRx Platform and Patient Discharge Solution to Fuel Patient-Centered Care and Improve Patient Outcomes
SAN FRANCISCO, Calif.— June 25, 2019 — PipelineRx, a leading medication management and telepharmacy company powered by clinical expertise and cloud technology, today announced that it has partnered with YouScript to offer powerful personalized prescribing tools on its PowerGridRx platform. YouScript is the leader in precision prescribing analytics and clinical decision support enabling gene-based prescribing at the point of care. Together, this partnership helps improve patient outcomes by ensuring each patient is on an optimal and safe medication regimen, thus reducing risk and readmissions, and lowering the overall cost of care. The technology is fully integrated with electronic health records and can service hospitals independently or with PipelineRx’s Patient Discharge Solution.
With 50 million Americans taking five or more medications and $528 billion spent addressing non-optimized drug regimens and adverse drug events (ADEs) each year, it is essential to understand how each prescription interacts with other medications or supplements – not just as drug-to-drug interactions, but also as drug-to-drug-to-drug, known as polypharmacy.¹ Further, research has revealed that half of all medications do not work as intended due to each individual’s unique genetics. The result is that non-optimized medication regimens lead to over 275,000 deaths yearly.¹
Addressing these growing concerns in medication management, the partnership between PipelineRx and YouScript will identify and stratify patients who are at risk of polypharmacy drug interactions or drug-gene interactions, enabling healthcare providers to focus on patients who are most likely to benefit from medication therapy changes. Onsite or remote pharmacists can then follow up with prescribers to make medication changes if appropriate. These interventions also help reduce costs by eliminating medications that are ineffective or have the potential to cause injury or death.
assesses the cumulative effect of a patient drug regimen and unique pharmacogenomic results with multiple peer-reviewed studies showing reductions in hospitalizations, ER visits and costs. Partnering with PipelineRx helps us achieve our mission to end avoidable adverse drug events by making our technology available exactly where it’s needed: at the point of care,” said YouScript CEO Kristine Ashcraft.
YouScript analyzes genetic data and the latest clinical knowledge on drug metabolism to identify and select prescription medications that will work best for each patient. For its polypharmacy solution, the platform looks beyond single drug-drug interactions to understand how a patient’s complete medication regimen interacts and provides actionable clinical insight if an intervention is needed. In a recently published study, the YouScript platform helped providers reduce re-hospitalizations and emergency department visits by 52% and 42% respectively, for improved outcomes, reduced costs, and high patient and provider satisfaction.²
“With the rise of personalized medicine, we want our pharmacists to feel empowered by the additional genomic information they have for patients – and be able to use this insight to improve medication management,” said Brian Roberts, CEO at PipelineRx. “Following the launch of our Patient Discharge Solution this spring, we are excited to introduce this new powerful addition and to continue innovating our comprehensive medication management solutions for our hospital and other partners.”
All functionality is available as a standalone service or in conjunction with PipelineRx’s Patient Discharge Solution, which helps onsite, or remote, pharmacists to prepare for and counsel patients as they leave your facility, then follow up to ensure medications are picked up and taken correctly after the patient has returned home. To learn more about the company’s comprehensive Patient Discharge solution, please visit our website or contact us.
At YouScript, our mission is to save lives, improve patient care and reduce costs by eliminating avoidable adverse drug events. Based on fifteen years of technology development that makes precision prescribing possible, Seattle-based YouScript was founded in 2016 after spinning out of Genelex. The YouScript clinical decision support tool is the only medication management system available that assesses the cumulative effect of a patient drug regimen and unique pharmacogenomic results. Based on over 17,000 curated references and product inserts, YouScript uses comprehensive predictive analytics to interpret and provide an at-a-glance summary of the complex web of genetics, medications, over-the-counters, herbals, and other factors impacting drug safety and response; identifying at risk patients for testing and offering ranked alternatives with reduced interaction risk whenever an adverse interaction risk is found.
¹October 2015; Journal of the American Medical Association
²Elliott LS, Henderson JC, Neradilek MB, Moyer NA, Ashcraft KC, Thirumaran RK. (2017) Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial. PLOS ONE 12(2): e0170905. doi: 10.1371/journal.pone.0170905
PipelineRx is a leader in comprehensive medication management solutions designed to advance pharmacy towards more outcomes-focused patient care. More than 500 facilities in the U.S. and Canada depend on PipelineRx each day to process more than 20 million medication orders annually. Combining the cloud-based platform, PowerGridRx™, with expert clinical pharmacy solutions, PipelineRx delivers a holistic approach that connects patients to their medications across care settings, and helps healthcare organizations of all sizes improve patient outcomes while reducing cost. For more information about PipelineRx, please visit www.pipelinerx.com or find the company on LinkedIn, Facebook, and Twitter.